Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May 28;108(10):2116-22.
doi: 10.1038/bjc.2013.167. Epub 2013 Apr 16.

Tumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer

Affiliations

Tumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer

A Carus et al. Br J Cancer. .

Abstract

Background: The prognostic impact of tumour-promoting immune cells in cervical cancer is unclear.

Methods: Federation of Gynaecology and Obstetrics (FIGO) stage IB and IIA cervical cancer patients (N=101) were assessed for tumour-associated CD66b(+) neutrophils and CD163(+) macrophages by immunohistochemistry in whole tissue sections using stereology. Results were correlated with previous results on tumour-infiltrating CD3(+), CD4(+), and CD8(+) lymphocytes in the same cohort with recurrence-free survival (RFS) as end point.

Results: The highest densities of CD66b(+) neutrophils and CD163(+) macrophages were observed in the peritumoural compartment (median 53.1 cells mm(-2) and 1.3% area fraction, respectively). Above median peritumoural and stromal CD66b(+) neutrophils and peritumoural CD163(+) macrophages were significantly associated with short RFS. Multivariate analysis identified high peritumoural neutrophils (HR 2.27; 95% CI 1.09-4.75; P=0.03), low peritumoural CD8(+) lymphocytes (HR 3.67; 95% CI 1.63-8.25; P=0.002), and lymph node metastases (HR 2.70; 95% CI 1.26-5.76; P=0.01) as independent prognostic factors for short RFS, whereas CD163(+) macrophages were not significant. An index of combined intratumoral and peritumoral CD66b(+) neutrophils to CD8(+) lymphocytes had good discriminatory power for each quartile with 5-year RFS of 92%, 80%, 62%, and 44% (P=0.001).

Conclusion: Tumour-associated neutrophil count is an independent prognostic factor for short RFS in localised cervical cancer. Combining CD66b and CD8 may further improve prognostic stratification. These findings require prospective validation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Representative example of CD66b+/CD34+ staining (20x lens) with tumour nest neutrophil (black thin arrow) and peritumoural neutrophil (white thin arrow). An unbiased counting frame is applied. (B) CD163+ immunostaining (20x lens) illustrating tumour nest macrophage (black fat arrow) and peritumoural macrophages (white fat arrow). A counting grid is applied.
Figure 2
Figure 2
Kaplan–Meier RFS curves according to peritumoural CD66b+ neutrophils (A), peritumoural CD163+ macrophages (B), and peritumoral CD8+ lymphocytes (C), all stratified by medians, and according to presence or absence of lymph node metastases (D). P-values obtained from log-rank tests.
Figure 3
Figure 3
Kaplan–Meier recurrence-free survival curves according to the TA-NLR stratified at quartiles from lower quartile I to highest quartile IV. P-value obtained from log-rank test.

References

    1. Ambarus CA, Krausz S, van Eijk M, Hamann J, Radstake TR, Reedquist KA, Tak PP, Baeten DL. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. J Immunol Methods. 2012;375 (1-2:196–206. - PubMed
    1. Ardi VC, Van den Steen PE, Opdenakker G, Schweighofer B, Deryugina EI, Quigley JP. Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway. J Biol Chem. 2009;284 (38:25854–25866. - PMC - PubMed
    1. Benedet JL, Bender H, Jones H, 3rd, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 2000;70 (2:209–262. - PubMed
    1. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132 (5:1133–1145. - PubMed
    1. Cho H, Kim JH. Multiplication of neutrophil and monocyte counts (MNM) as an easily obtainable tumour marker for cervical cancer. Biomarkers. 2009;14 (3:161–170. - PubMed

Publication types

MeSH terms